Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

1.37
Delayed Data
As of 3:59pm ET
 -0.05 / -3.52%
Today’s Change
0.61
Today|||52-Week Range
3.50
+63.06%
Year-to-Date

Today’s Trading

Previous close1.42
Today’s open1.45
Day’s range1.37 - 1.45
Volume664,592
Average volume (3 months)2,264,700
Market cap$79.1M
Dividend yield--
Data as of 3:59pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)+51.90%
Earnings growth (this year)+43.07%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,301.62%
P/E ratioNM
Price/Sales2.42
Price/Book3.60

Competitors

 Today’s
change
Today’s
% change
OGXIOncoGenex Pharmaceut...+0.23+8.58%
CNATConatus Pharmaceutic...-0.12-2.96%
OGENOragenics Inc+0.04+1.80%
MSTXMast Therapeutics In...+0.02+3.19%
Data as of 4:01pm ET, 08/31/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$18.1M
Annual profit (last year)-$52.7M
Net profit margin-291.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers